A new platform has enabled an unprecedented level of control over individual molecules and particles on a chip for high-throughput analysis.
List view / Grid view
Rachael Harper (Drug Target Review)
Filter the results
A new study has identified possible regulators that determine differences in cancer tumours between genders.
Researchers may have fundamentally altered the way scientists study brain diseases with new CRISPR technology.
Two genes that influence risk Alzheimer's disease could provide scientists with new targets for delaying the onset of the condition's symptoms.
A molecular switch that impacts immune responses to viral infections has been identified which could lead to better strategies to develop vaccines.
Researchers have discovered that removing the enzyme, PHLPP1, improves outcomes in a mouse model of sepsis so could be a potential drug target.
A new study has found that damage caused by Alzheimer's allows toxins to enter the brain, further harming neurons.
New research into sex-based differences of Parkinson's disease could lead to new treatments.
The cause and trigger of the large clumps of protein beta-amyloid found in the brains of early-stage Alzheimer's patients have been discovered.
A chaperone protein has been identified as a possible therapeutic target for the treatment of Kennedy's disease and prostate cancer.
Researchers have identified a pathway in the immune system activated in Crohn's disease which could lead to investigating new treatments.
A research team have used genome editing to correct two of the mutations that cause cystic fibrosis.
The ISCT is objecting linking the benefits of cellular immunotherapy with third party offerings of T-cell banking for future therapeutics.
A new drug called IP1867B, which could be used for future treatments of brain tumours, is being examined.